retatrutide status vs Tirzepatide vs Semaglutide Retatrutide FDA Approval Status: July

This is the "Research Flywheel" in action: turning crowdsourced data into scientific breakthroughs, and then into tools that change lives

As the Ozempic craze continues in kind, websites are now purporting to sell knockoffs of the injectable drug without a prescription.

Discover why obesity specialists may hesitate to recommend weight-loss drugs alone and what alternatives they discuss for lasting results.

PlushCare is a telemedicine platform that offers same-day appointments for primary, urgent, and mental health care

It's a fillip for new Novo Nordisk chief executive Mike Doustdar, who took the helm last year with a clear remit to defend the GLP-1-based weight loss and diabetes business from rivals like Eli Lilly, as well as knock-off versions of semaglutide that sidestep the company's intellectual property (IP).

Understanding your personal timeline helps set realistic expectations for sustainable results